CN3 – Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

A. Miquel Cases, L.M.G. Steuten, V.P. Retèl, W.H. van Harten

    Research output: Contribution to journalMeeting AbstractOther research output

    44 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'CN3 – Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy'. Together they form a unique fingerprint.

    Medicine and Dentistry